Intersect ENT, Inc.
CIK 0001271214
Revenue (TTM)
$97.65M
+32.5% YoY
Q1 Apr 2022
Net Income (TTM)
−$97.29M
−120.7% YoY
Q1 Apr 2022
EPS Diluted (TTM)
−$2.91
Q1 Apr 2022
Gross Margin
69.7%
Q1 Apr 2022
Operating Margin
-80.1%
Q1 Apr 2022
Net Margin
-99.6%
Q1 Apr 2022
Free Cash Flow (TTM)
−$58.45M
Q1 Apr 2022
Cash
$25.59M
Q1 Apr 2022
Total Debt
$142.61M
Q1 Apr 2022
Shares Outstanding
33.81M sh
Q1 Apr 2022